RIKEN Center for Computational Science HPC- and AI-driven Drug Development Platform Division
Director: Yasushi Okuno (Ph.D.)
Research Summary
Life science in the future cannot be fully advanced by practicing data science, simulation science, and experimental science independent of each other. Deep integration of these fields is essential in order to discover unexplored biological phenomena. This Division aims to develop novel methodologies to integrate AI, molecular simulation, and experimental sciences and establish an integrated platform for HPC- and AI-driven drug development. In doing so, we will explore the frontier of life science, drug development, and healthcare.
Main Research Fields
- Medicine, Dentistry & Pharmacy
Related Research Fields
- Informatics
- Complex Systems
- Interdisciplinary Science & Engineering
Keywords
- Creation of new life science by integrating simulation, AI, and experimental sciences
- Development of novel types of drugs and treatments (from small molecules to large molecules; from basic to clinical applications)
- Establishment of an integrated platform for HPC- and AI-driven life science
- Practical application of drug development, healthcare, and life science
Related Links
Lab Members
Principal investigator
- Yasushi Okuno
- Director
Core members
- Teruki Honma
- Deputy Division Director
Careers
| Position | Deadline |
|---|---|
| Seeking Deputy Division Director (K24113) | Open until filled |
Contact Information
7-1-26, Minatojima-minami-machi,
Chuo-ku, Kobe,Hyogo
650-0047, Japan
Email: yasushi.okuno [at] riken.jp
Organization
- Biomedical Computational Intelligence Unit
- Yasushi Okuno (Ph.D.)
- Medicinal Chemistry Applied AI Unit
- Kazuyoshi Ikeda (Ph.D.)
- Molecular Design Computational Intelligence Unit
- Mitsunori Ikeguchi (Ph.D.)
- AI-driven Drug Discovery Collaborative Unit
- Yasushi Okuno (Ph.D.)